Mass. Ruling Doesn't End NJ Eyedrops Case, 3rd Circ. Told

Law360, New York (October 12, 2017, 5:15 PM EDT) -- A potential class of eyedrops users alleging generic-drug makers such as Sandoz Inc. boosted prescription sales by using bottles that dispensed larger-than-needed drops told the Third Circuit Wednesday that a suit tossed in Massachusetts shouldn't end theirs.

An attorney for the patients blasted a Massachusetts federal judge’s finding in Gustavsen v. Alcon Laboratories Inc. — which involves the same defendants — that the drug companies couldn’t make the product changes the plaintiffs contended were required by state law without violating federal law, responding to the companies’...
To view the full article, register now.